goa conference 2023
6-8 sept 2023
LISBOA BALL ROOM, Radisson Blu Resort, Goa
6 sept – day 1
8:00-8:20
am
Registration
Outside LISBOA Ball Room
8:20-8:35
am
Welcome & Introduction
Sudha Srinivasan, National Institutes of Health, USA, Jyoti Logani, Department of Biotechnology, India, Jerry Ellner, RePORT International
8:35-8:50
am
Overview of RePORT India & RePORT International
Sonali Sarkar, RePORT India & Jerry Ellner, RePORT International
8:50-9:00
am
Role of RePORT International in NIAID TB Programs
Peter Kim/Fatima Jones, National Institutes of Health, USA
9:00-9:30
am
Keynote Address
Rajesh Gokhale, Secretary for Department of Biotechnology & Department of Science & Technology, Government of India
Basic Research – MTb Survival
Dhiraj Kumar & Padmini Salgame
9:30-9:55
am
Delineating Survival Strategies Employed by Mycobacterium Tuberculosis
Vinay Nandicoori, CSIR-Centre for Cellular & Molecular Biology
9:55-10:20
am
Targeting Host-Pathogen Heterogenous Interactions to Counteract Drug Tolerance in M. Tuberculosis
Amit Singh, Indian Institute of Science (IISc) Bangalore
10:20-10:45
am
Mycobacterium Tuberculosis Biofilms: Their Role in Drug Tolerance & Immune Evasion
Ashwani Kumar, CSIR – Institute of Microbial Technology
10:45-11:00 AM
Coffee & Tea Break
Vaccines
Amit Singh & Mark Hatherill
11:00-11:25
am
Vaccines to Prevent TB Infection & Immunology
Mark Hatherill & Tom Scriba, RePORT South Africa
11:25-11:50
am
Vaccines: VPM
Umesh Shaligram, Serum Institute
11:50-12:15
am-pm
VPM1002 Overview & Immunology
Vidya Mave & Padmini Salgame, RePORT India
12:15-12:40
pm
VPM1002 ICMR Trial in Close Contacts
Manjula Singh, ICMR
12:40-1:00
pm
IeDEA Tuberculosis Sentinel Research Network (TB-SRN)
Jeremy Ross, IeDEA
1:00 – 1:20
pm
Innovation in AI Based TB Case Finding
Shibu Vijayan, Qure.ai
1:20 PM
Group Photo & Lunch
operational agenda
Break Out Session, Members Only
2:30-4:00
pm
Bylaws Committee
Stephany Duda
4:00-4:15 PM
Coffee & Tea Break
4:15-5:45
pm
Scientific Review Committee
Tim Sterling & Mark Hatherill
6:30 PM
Networking Dinner
7 sept – day 2
8:00-8:15
am
Introduction & Overview of TB Survivors Program in India
Amita Gupta, RePORT India & Chapal Mehra, TB Survivors
8:15-8:30
am
A TB Survivor’s Journey
Dipti Chavan, TB Survivors Program
8:30-8:50
am
Lung Health Study Updates
Hardy Kornfeld, UMass Chan Medical School – Worcester
Early TB
Vijaya Valluri & Bruno Andrade
8:50-9:15
am
Subclinical TB: What we have Learned from a Community-Based Study in KwaZulu-Natal
Emily Wong, AHRI
9:15-9:40
am
PET-CT & Biomarkers in Subclinical TB
Anna Coussens, Walter and Eliza Hall Institute (WEHI)
9:40-10:05
am
Modeling Sub Clinical TB
Tess Rykman, Johns Hopkins University
10:05-10:20
am
Incidence & Determinants of Subclinical & Clinical Recurrence of Tuberculosis among Cured Pulmonary Tuberculosis Patients in India
Mandar Paradkar, RePORT India (Junior Investigator)
10:20-10:35
am-pm
A Comprehensive Multiomic Analysis of the Tuberculosis & Diabetes Interaction
Mariana Araújo Pereira, RePORT Brazil (Junior Investigator)
10:35-10:50 AM
Coffee & Tea Break
Sub Clinical TB
DJ Christopher & Tim Sterling
10:50-11:05
am
Gene Signatures for Monitoring Treatment
Response & Predicting Cure Among TB
Patients in Brazil
Simon C Mendelsohn, RePORT South Africa (Junior Investigator)
11:05-11:20
am
Impact of Premorbid Nutritional Status on
Tuberculosis Severity in India: A Multicenter Prospective Cohort Analysis
Komal Jain (on behalf of Xinyi Du), RePORT India (Junior Investigator)
11:20-11:35
am
The Sound of Silent RNA: The Role of Long Non-Coding RNA on Tuberculosis in 4 Different Populations
Artur Trancoso Lopo de Queiroz, RePORT Brazil (Junior Investigator)
11:35-11:50
am
Population Pharmacokinetics of Moxifloxacin in Indian Patients with Multidrug-Resistance Tuberculosis
Prerna Arora, RePORT India (Junior Investigator)
11:50-12:15
am-pm
IGRA Conversion/Reversion
Sheetal Verma, Rutgers University
12:15-12:40
pm
Immune Biomarkers for TB Progression in a Cohort Study of Household Contact
Prudhula Kamakshi, Bhagwan Mahavir Medical Research Centre
12:40-1:05
pm
Urine & Serum Biomarker Analyses in Cohort B samples from RePORT South Africa
Karen Dobos & John Belisle, Colorado State University
1:05-1:25
pm
Towards a Systems Pharmacology Mathematical Model for EPTB
Chetan Gadgil, National Chemical Laboratory, Pune
1:25-1:40
pm
Introduction to SMART4TB
Bob Bollinger, Johns Hopkins University
1:40-2:00
pm
Closing of Scientific Sessions
DJ Christopher & Mark Hatherill
2:00 PM
Poster Session & Lunch Break
operational agenda
Break Out Session, Members Only
2:45 – 4:15
pm
Common Protocol
Stephany Duda & Ann Tufariello
4:15-4:30 PM
Coffee & Tea Break
4:30-6:00
pm
Capacity Strengthening
Bob Bollinger & Valeria Rolla
FREE Evening
8 sept – day 3
Scientific Country Updates
Stephany Duda & Marissa Alejandria
8:00-8:20
am
RePORT Brazil
Country Representative
8:20-8:40
am
RePORT India
Country Representative
8:40-9:00
am
RePORT Indonesia
Country Representative
9:00-9:15
am
RePORT Korea
Country Representative
9:15-9:35
am
RePORT Philippines
Country Representative
9:35-9:55
am
RePORT South Africa
Country Representative
9:55-10:10
am
RePORT Uganda
Country Representative
10:10-10:30 AM
Coffee & Tea Break
Working Group & Protocol
Action Items & Approvals
10:35-10:55
am
Biomarker Protocol
Padmini Salgame
10:55-11:15
am
Data Harmonization
Stephany Duda & Sri Ram Pentakota
11:15-11:35
am
Scientific Review Committee
Tim Sterling & Mark Hatherill
11:35-12:00
am-pm
Capacity Strengthening
Bob Bollinger
12:00-12:30
pm
Bylaws Committee
Stephany Duda
12:30-1:00
pm
Common Protocol
Stephany Duda & Ann Tufariello
1:30 PM
Closing & Lunch, Meeting Co-Chairs
What's new
Collaborative Research Innovation
Fostering Collaborative Research and Innovation in TBThe 13th RePORT India Annual Meeting held from 3-5 April 2024, at the National Institute of Immunology (NII) in New Delhi.The 13th RePORT India Annual Meeting was held from 3-5 April 2024, at the National Institute...
Ending TB
Ending TBEnding TB: The Critical Role of Determinants
Decoding TB
Is TB Care Humanistic?Is Tuberculosis Care Humanistic? What the Latest Evidence Reveals